viewFSD Pharma

FSD Pharma to ring CSE opening bell Friday

It is celebrating its status as the first CSE-listed company to dual-list on a major US exchange

Raza Bokhari
CEO Raza Bokhari, co-founders Anthony Durkacz and Zeeshan Saeed, and other members of the company’s leadership team will represent FSD in Toronto

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) has accepted an invitation to ring the opening bell at the Canadian Securities Exchange (CSE) on Friday.

CEO Raza Bokhari, co-founders Anthony Durkacz and Zeeshan Saeed, and other members of the company’s leadership team will represent the pharmaceutical cannabis research company at the CSE Media Centre in Toronto. 

The event will be live-streamed on the CSE's Instagram and YouTube channels starting at 9:28 am ET, with the bell ringing sounding off at 9:30 am.

READ: FSD Pharma Inc generates $7.7M in proceeds through sale of interest in Cannara Biotech

"We are immensely thrilled to ring the opening bell at the CSE to celebrate our accomplishment as the first CSE-listed company to dual-list onto a major US stock exchange," Bokhari said in a statement.

"Having raised a record $53 million in pre-listing capital and following our listing on the CSE in May 2018, we have continued to demonstrate a track record of success that is reflected in trading liquidity that tops 6 billion shares to date that is among the volume leaders on the CSE.”

The Toronto-based company started trading on the Nasdaq on January 9 and got to ring the opening bell in New York later that month. 

"Today, we are among a select group of 12 Canadian-domiciled, cannabis-related companies that trade on a major US exchange,” Bokhari said. “I am very hopeful that sooner rather than later, we will be placed in a league of our own as we continue to demonstrate that the primary thrust of our business is to conduct US FDA-approved clinical trials on synthetic compounds with anti-inflammatory properties that target the endocannabinoid system of the human body."

Officials at the CSE were impressed at how far FSD has come. 

"Entrepreneurs around the world have come to recognize the CSE as the ideal platform from which to access low-cost capital,” CSE CEO Richard Carleton said. “We celebrate one of our own in FSD Pharma as an emerging leader in the marketplace. What Raza and his leadership team have built serves as a roadmap for other entrepreneurs supported by CSE as their pre-eminent global listing venue."

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: FSD Pharma

Price: 2.4 CAD

Market: CSE
Market Cap: $45.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...


FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end...

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) CEO Raza Bokhari tells Proactive the group has submitted an Investigational New Drug (IND) application to the FDA for the use of its lead candidate FSD-201, or anti-inflammatory ultra-micronized-palmitoylethanolamide (PEA), to treat...

on 09/10/2020

2 min read